To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SCRN2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
274 supporting clones for gene SCRN2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DR155718 human embryonic stem cells differentiated toan early endodermal cell type .a 1 to 172 1 to 172   tiling clone,   172/172
(100 %)
2 diff
(98.9 %id)
DR003172 fetal brain .a 11 to 506 1 to 493       493/493
(100 %)
10 diff
(98.0 %id)
CN294985 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 14 to 262 1 to 251       251/251
(100 %)
2 diff
(99.3 %id)
BU845673 ovary, teratocarcinoma, cell line .a 14 to 883 1 to 876       876/935
(93 %)
17 diff
(98.2 %id)
BI755657 brain .a 27 to 793 1 to 786       786/868
(90 %)
28 diff
(96.8 %id)
TI_57218545   .a 27 to 793 36 to 821       786/903
(87 %)
32 diff
(96.5 %id)
BQ940020 sciatic nerve .a 47 to 505 1 to 459       459/1041
(44 %)
8 diff
(99.3 %id)
CR590226 Neuroblastoma Cot 25-normalized .a 49 to 1793 1 to 1745 exact tiling clone,   1745/1745
(100 %)
0 diff
(100 %id)
AL524067 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 49 to 940 1 to 884       884/1053
(83 %)
12 diff
(98.9 %id)
CB265706 adipose .a 78 to 342 1 to 266       266/271
(98 %)
3 diff
(98.9 %id)
BI913369 brain .a 89 to 912 1 to 828       828/829
(99 %)
21 diff
(97.5 %id)
TI_57240331   .a 89 to 934 36 to 886       851/933
(91 %)
26 diff
(97.3 %id)
BI913709 brain .a 94 to 940 1 to 855       855/857
(99 %)
19 diff
(97.8 %id)
TI_57241330   .a 94 to 940 32 to 886       855/888
(96 %)
24 diff
(97.3 %id)
BX405159 T cells (Jurkat cell line) .a 196 to 694 1 to 500       456/500
(91 %)
24 diff
(95.2 %id)
BI837562 pooled pancreas and spleen .a 206 to 1016 1 to 814       814/814
(100 %)
9 diff
(98.9 %id)
TI_57165640   .a 206 to 1016 35 to 848       814/848
(95 %)
10 diff
(98.9 %id)
BM919841 pooled pancreas and spleen .a 207 to 1130 1 to 928       928/993
(93 %)
11 diff
(98.9 %id)
BX463145 fetal liver, Liver .a 232 to 1260 1 to 1021       1021/1049
(97 %)
17 diff
(98.4 %id)
TI_57182272   .a 249 to 1037 28 to 813       786/813
(96 %)
9 diff
(98.9 %id)
BI771605 pooled lung and spleen .a 251 to 1037 1 to 784       784/784
(100 %)
5 diff
(99.4 %id)
BX433345 fetal liver, Liver .a 305 to 1224 917 to 1       917/917
(100 %)
11 diff
(98.9 %id)
AA340672 Kidney .a 331 to 735 1 to 403       403/439
(91 %)
10 diff
(97.8 %id)
BF530911 anaplastic oligodendroglioma with 1p/19qloss, brain .a 357 to 1112 1 to 749       749/880
(85 %)
18 diff
(98.0 %id)
AL524066 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 932 to 1793 860 to 1       860/1040
(82 %)
6 diff
(99.5 %id)
NM_138355.3   .b 1 to 1565 1 to 1565 exact RefSeq, AAA   1565/1565
(100 %)
0 diff
(100 %id)
CR591968 Neuroblastoma Cot 50-normalized .b 50 to 1548 1 to 1499 exact tiling clone,   1499/1499
(100 %)
0 diff
(100 %id)
BX355221 Neuroblastoma Cot 50-normalized .b 50 to 899 1 to 847       847/978
(86 %)
5 diff
(99.5 %id)
CR602946 T cells (Jurkat cell line) Cot10-normalized .b 67 to 1526 1 to 1460 exact     1460/1460
(100 %)
0 diff
(100 %id)
AL558432 T cells from T cell leukemia .b 67 to 806 1 to 739   fully sequenced,   739/739
(100 %)
1 diff
(99.9 %id)
BG491736 amelanotic melanoma, cell line, skin .b 84 to 688 1 to 616       616/778
(79 %)
20 diff
(97.5 %id)
BC010408 Lung, small cell carcinoma .b 87 to 1556 1 to 1470 M323V tiling clone, available from MGC, AAA   1470/1470
(100 %)
2 diff
(99.9 %id)
BC017317 Skin, melanotic melanoma. .b 88 to 1556 1 to 1469 K103R M323V S411G available from MGC, AAA   1469/1469
(100 %)
3 diff
(99.8 %id)
CR613816 Placenta Cot 25-normalized .b 88 to 1520 1 to 1433 exact     1433/1433
(100 %)
0 diff
(100 %id)
BX399669 Placenta Cot 25-normalized .b 88 to 954 1 to 861   fully sequenced,   861/861
(100 %)
4 diff
(99.6 %id)
CR595401 Neuroblastoma Cot 10-normalized .b 94 to 1543 1 to 1450 exact     1450/1450
(100 %)
0 diff
(100 %id)
AL520945 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .b 94 to 806 1 to 712   fully sequenced,   712/712
(100 %)
1 diff
(99.9 %id)
AK290646 whole embryo, mainly head .b 98 to 1500 1 to 1403 M323V     1403/1403
(100 %)
2 diff
(99.9 %id)
BX382669 Placenta Cot 25-normalized .b 99 to 761 1 to 662       662/662
(100 %)
6 diff
(99.1 %id)
CR604407 Neuroblastoma Cot 25-normalized .b 101 to 1543 1 to 1443 exact     1443/1443
(100 %)
0 diff
(100 %id)
AL523220 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 101 to 1064 1 to 963       963/1116
(86 %)
8 diff
(99.3 %id)
TI_1948085698   .b 127 to 740 130 to 745   fully sequenced,   615/744
(82 %)
11 diff
(98.6 %id)
TI_1948086009   .b 127 to 787 128 to 791   fully sequenced,   663/790
(83 %)
13 diff
(98.4 %id)
TI_1948086164   .b 127 to 688 129 to 691       562/1467
(38 %)
12 diff
(99.2 %id)
TI_1948225759   .b 127 to 808 125 to 812   fully sequenced,   686/810
(84 %)
10 diff
(98.8 %id)
TI_1948225901   .b 127 to 803 129 to 810   fully sequenced,   681/809
(84 %)
10 diff
(98.8 %id)
TI_1948226048   .b 127 to 775 131 to 780   fully sequenced,   649/779
(83 %)
6 diff
(99.3 %id)
TI_1948226195   .b 127 to 867 126 to 868   fully sequenced,   742/867
(85 %)
8 diff
(99.1 %id)
BM127089 Islets of Langerhans, Pancreas .b 178 to 738 1 to 561       561/561
(100 %)
0 diff
(100 %id)
BI522207 pooled pancreas and spleen .b 618 to 1497 922 to 7       824/1001
(82 %)
47 diff
(95.4 %id)
TI_149302897   .b 678 to 1556 951 to 75   AAA   877/985
(89 %)
14 diff
(98.6 %id)
TI_1948085846   .b 681 to 1403 852 to 122       731/1486
(49 %)
17 diff
(98.9 %id)
BX414130 T cells (Jurkat cell line) .b 683 to 1537 853 to 4       850/862
(98 %)
21 diff
(97.6 %id)
TI_1948085699   .b 713 to 1403 817 to 127   fully sequenced,   691/817
(84 %)
8 diff
(99.1 %id)
TI_1948086165   .b 713 to 1403 808 to 121       688/1358
(50 %)
6 diff
(99.6 %id)
BI519525 leukocyte .b 733 to 1496 781 to 10       770/781
(98 %)
27 diff
(96.6 %id)
TI_44459378   .b 733 to 1496 781 to 10       770/781
(98 %)
27 diff
(96.6 %id)
TI_1948226049   .b 745 to 1403 783 to 125   fully sequenced,   659/783
(84 %)
1 diff
(99.9 %id)
TI_182940156   .b 752 to 1556 904 to 107   AAA   798/937
(85 %)
18 diff
(98.1 %id)
TI_1948086010   .b 757 to 1403 772 to 123   fully sequenced,   650/772
(84 %)
1 diff
(99.9 %id)
AW006952 colon .b 772 to 1556 786 to 3       784/786
(99 %)
20 diff
(97.5 %id)
TI_1948225902   .b 773 to 1403 758 to 125   fully sequenced,   634/758
(83 %)
1 diff
(99.9 %id)
AL520944 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .b 776 to 1543 766 to 1   fully sequenced,   766/766
(100 %)
11 diff
(98.6 %id)
AL580255 T cells from T cell leukemia .b 776 to 1497 753 to 30   fully sequenced,   724/730
(99 %)
5 diff
(99.4 %id)
TI_1948225760   .b 778 to 1403 764 to 127   fully sequenced,   638/764
(83 %)
9 diff
(98.9 %id)
BM981010 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 818 to 1556 757 to 19   AAA   739/739
(100 %)
4 diff
(99.5 %id)
BX382668 Placenta Cot 25-normalized .b 819 to 1427 612 to 3       610/612
(99 %)
25 diff
(96.0 %id)
TI_1948226196   .b 837 to 1403 690 to 124   fully sequenced,   567/690
(82 %)
1 diff
(99.9 %id)
BX405158 T cells (Jurkat cell line) .b 852 to 1545 696 to 1       696/867
(80 %)
16 diff
(98.2 %id)
CR981945 T-Lymphocytes .b 857 to 1551 1 to 695       695/695
(100 %)
2 diff
(99.8 %id)
CB048035 Prostate .b 867 to 1477 10 to 620       611/620
(98 %)
8 diff
(98.8 %id)
BU620861 cell lines, Chondrosarcoma .b 883 to 1556 690 to 19   AAA   672/672
(100 %)
4 diff
(99.5 %id)
CN480733 Aveolar Macrophage, lung .b 891 to 1556 684 to 19   AAA   666/666
(100 %)
0 diff
(100 %id)
BU633053 cell lines, Chondrosarcoma .b 894 to 1556 678 to 19   AAA   660/672
(98 %)
6 diff
(99.2 %id)
BX372951 Neuroblastoma Cot 50-normalized .b 899 to 1544 648 to 4       645/825
(78 %)
10 diff
(98.8 %id)
BG492190 amelanotic melanoma, cell line, skin .b 899 to 1497 630 to 11       620/630
(98 %)
10 diff
(98.5 %id)
BX399668 Placenta Cot 25-normalized .b 924 to 1516 598 to 4   fully sequenced,   595/598
(99 %)
8 diff
(98.7 %id)
BM998539 lung, Metastatic Chondrosarcoma .b 971 to 1556 604 to 19   AAA   586/587
(99 %)
7 diff
(98.9 %id)
TI_57168490   .b 986 to 1525 53 to 595       543/1009
(53 %)
11 diff
(99.0 %id)
BI832942 pooled pancreas and spleen .b 994 to 1525 1 to 535       535/949
(56 %)
6 diff
(99.4 %id)
AA643065 epithelium (cell line), Prostate .b 1003 to 1556 554 to 3       552/554
(99 %)
8 diff
(98.6 %id)
BE792795 lung, small cell carcinoma .b 1012 to 1556 36 to 578       543/579
(93 %)
9 diff
(98.5 %id)
AA595164 breast .b 1024 to 1556 547 to 15   AAA   533/533
(100 %)
8 diff
(98.5 %id)
BF063362 colon, colon tumor, RER+ .b 1024 to 1562 540 to 2       539/540
(99 %)
1 diff
(99.9 %id)
AA580017 breast .b 1036 to 1555 516 to 1       516/516
(100 %)
8 diff
(98.5 %id)
AI697133 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .b 1048 to 1562 514 to 1       514/514
(100 %)
5 diff
(99.1 %id)
AL523219 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 1056 to 1543 488 to 1       488/1041
(46 %)
5 diff
(99.6 %id)
AW612440 Kidney .b 1056 to 1556 504 to 4       501/506
(99 %)
3 diff
(99.5 %id)
BM126778 Islets of Langerhans, Pancreas .b 1065 to 1556 502 to 12   AAA   491/491
(100 %)
1 diff
(99.8 %id)
AI201976 Prostate .b 1072 to 1556 491 to 7       485/491
(98 %)
2 diff
(99.6 %id)
AI088096 pooled .b 1094 to 1556 468 to 6       463/478
(96 %)
0 diff
(100 %id)
AI799880 Prostate .b 1140 to 1556 437 to 21   AAA   417/417
(100 %)
5 diff
(98.9 %id)
CA426941 Bone, Subchondral Bone .b 1141 to 1556 434 to 19   AAA   416/418
(99 %)
3 diff
(99.3 %id)
AI560641 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 1163 to 1556 435 to 42   AAA   394/395
(99 %)
15 diff
(96.3 %id)
AI829011 2 pooled tumors (clear cell type), Kidney .b 1163 to 1565 414 to 12   AAA   403/404
(99 %)
16 diff
(96.1 %id)
TI_57183552   .c 1 to 859 28 to 893   tiling clone,   866/900
(96 %)
27 diff
(97.0 %id)
BI770643 pooled lung and spleen .c 2 to 859 1 to 865   tiling clone,   865/872
(99 %)
23 diff
(97.4 %id)
NM_001145023.1   .c 2 to 1833 1 to 1832 exact RefSeq, AAA   1832/1832
(100 %)
0 diff
(100 %id)
AK303835 ovary, tumor tissue .c 46 to 1537 1 to 1492 M323V     1492/1492
(100 %)
2 diff
(99.9 %id)
BQ109576 brain .c 46 to 763 1 to 720       717/720
(99 %)
13 diff
(98.2 %id)
DC413604 ovary, tumor tissue .c 46 to 601 1 to 556       556/556
(100 %)
0 diff
(100 %id)
BP245757 Kidney .c 56 to 640 1 to 582       584/582
(100 %)
12 diff
(98.0 %id)
BP247853 Kidney .c 56 to 643 1 to 587       587/587
(100 %)
12 diff
(98.0 %id)
CR611349 T cells (Jurkat cell line) Cot10-normalized .c 57 to 1739 1 to 1683 exact tiling clone,   1683/1683
(100 %)
0 diff
(100 %id)
BX400187   .c 57 to 983 1 to 922   fully sequenced,   922/922
(100 %)
3 diff
(99.7 %id)
BC002980 Lung, small cell carcinoma .c 59 to 1824 1 to 1766 M323V tiling clone, available from MGC, AAA   1766/1766
(100 %)
2 diff
(99.9 %id)
BI548905 brain, hippocampus .c 61 to 900 1 to 839       839/845
(99 %)
7 diff
(99.2 %id)
BE241711 leukopheresis .c 61 to 137 1 to 77       77/110
(70 %)
2 diff
(98.2 %id)
BE241910 leukopheresis .c 61 to 181 1 to 121       121/121
(100 %)
3 diff
(97.6 %id)
BP245000 Kidney .c 62 to 642 1 to 582       582/582
(100 %)
5 diff
(99.2 %id)
TI_44166706   .c 62 to 900 85 to 922       838/928
(90 %)
12 diff
(98.8 %id)
TI_44459376   .c 66 to 857 57 to 848       792/851
(93 %)
8 diff
(99.1 %id)
CK430559 eye, lacrimal gland .c 66 to 690 1 to 625       625/625
(100 %)
0 diff
(100 %id)
BI913458 brain .c 67 to 948 1 to 879       879/921
(95 %)
7 diff
(99.3 %id)
BM908149 brain, medulla .c 67 to 890 16 to 853       838/1152
(72 %)
30 diff
(97.4 %id)
TI_57240497   .c 67 to 948 35 to 913       879/955
(92 %)
13 diff
(98.7 %id)
BE799331 lung, small cell carcinoma .c 70 to 850 3 to 782       780/782
(99 %)
9 diff
(98.9 %id)
BG336489 choriocarcinoma, placenta .c 71 to 829 1 to 761       761/1048
(72 %)
37 diff
(96.5 %id)
BG823707 adenocarcinoma cell line, colon .c 71 to 813 1 to 759       759/759
(100 %)
19 diff
(97.5 %id)
CR606349 Neuroblastoma Cot 25-normalized .c 72 to 1793 1 to 1722 exact     1722/1722
(100 %)
0 diff
(100 %id)
BX354741 Neuroblastoma Cot 25-normalized .c 72 to 953 1 to 871   fully sequenced,   871/871
(100 %)
3 diff
(99.7 %id)
BG771269 adenocarcinoma, Prostate .c 73 to 726 1 to 653       653/653
(100 %)
4 diff
(99.4 %id)
BI518889 leukocyte .c 73 to 857 1 to 785       785/788
(99 %)
2 diff
(99.8 %id)
BI521372 pooled pancreas and spleen .c 73 to 661 1 to 592       592/592
(100 %)
3 diff
(99.5 %id)
AL709844 human skeletal muscle .c 74 to 666 1 to 591       591/591
(100 %)
5 diff
(99.2 %id)
DC393513 colon, tumor tissue .c 74 to 420 1 to 347       347/347
(100 %)
0 diff
(100 %id)
BX418898 brain, fetal brain .c 79 to 890 1 to 811       811/821
(98 %)
20 diff
(97.6 %id)
BE264236 lung, small cell carcinoma .c 79 to 561 1 to 482   available from MGC,   482/483
(99 %)
4 diff
(99.2 %id)
BM545052 ovary (pool of 3) .c 79 to 750 9 to 681       673/1167
(57 %)
12 diff
(99.0 %id)
BX375119 Neuroblastoma Cot 25-normalized .c 80 to 1058 1 to 971       971/974
(99 %)
16 diff
(98.4 %id)
CD514894 White Matter .c 80 to 886 1 to 817       817/915
(89 %)
23 diff
(97.5 %id)
CN255170 embryonic stem cells, DMSO-treated H9 cellline .c 81 to 882 1 to 802       802/802
(100 %)
5 diff
(99.4 %id)
BM009848 amelanotic melanoma, cell line, skin .c 85 to 739 1 to 656       656/658
(99 %)
22 diff
(96.7 %id)
BM552252 leiomyosarcoma, uterus .c 85 to 881 1 to 806       806/1076
(74 %)
16 diff
(98.6 %id)
CN255161 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 86 to 860 8 to 784       777/784
(99 %)
8 diff
(99.0 %id)
TI_59384624   .c 86 to 739 118 to 772       655/657
(99 %)
21 diff
(96.9 %id)
BG255910 adenocarcinoma, cell line, Prostate .c 87 to 797 1 to 717       717/932
(76 %)
33 diff
(96.5 %id)
AL528642 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .c 89 to 1067 1 to 978       978/1129
(86 %)
24 diff
(97.9 %id)
TI_57221438   .c 89 to 900 83 to 902       820/1115
(73 %)
23 diff
(98.0 %id)
TI_57229512   .c 89 to 940 73 to 927       855/856
(99 %)
8 diff
(99.1 %id)
BI870582 adenocarcinoma, cell line, Liver .c 90 to 940 1 to 854       854/855
(99 %)
8 diff
(99.1 %id)
BE733151 choriocarcinoma, placenta .c 91 to 874 1 to 781       781/912
(85 %)
19 diff
(98.0 %id)
BE512870 adenocarcinoma cell line, colon .c 92 to 759 1 to 670       670/670
(100 %)
8 diff
(98.9 %id)
CN255167 embryonic stem cells, cell lines H1, H7, andH9 .c 93 to 787 1 to 695       695/695
(100 %)
0 diff
(100 %id)
BX353232 Neuroblastoma Cot 25-normalized .c 93 to 1059 1 to 960       960/967
(99 %)
9 diff
(99.1 %id)
CB159059 Liver .c 93 to 643 1 to 551       551/551
(100 %)
0 diff
(100 %id)
BG819778 anaplastic oligodendroglioma with 1p/19qloss, brain .c 94 to 869 1 to 776       776/776
(100 %)
4 diff
(99.5 %id)
BI757912 brain .c 94 to 900 1 to 815       815/1028
(79 %)
16 diff
(98.5 %id)
BM924407 pooled colon, kidney, stomach .c 96 to 887 1 to 806       806/1129
(71 %)
17 diff
(98.5 %id)
CD516679 White Matter .c 96 to 881 1 to 800       800/847
(94 %)
17 diff
(98.0 %id)
BE276813 melanotic melanoma, skin .c 97 to 717 1 to 616       619/661
(93 %)
9 diff
(98.7 %id)
BE391952 endometrium, adenocarcinoma cell line, uterus .c 100 to 689 4 to 593       590/705
(83 %)
14 diff
(98.1 %id)
AA013305 eye, retina .c 102 to 438 1 to 345       345/359
(96 %)
14 diff
(96.2 %id)
BE252644 eye, retinoblastoma .c 109 to 768 1 to 657       657/658
(99 %)
6 diff
(99.1 %id)
BE728954 melanotic melanoma, skin .c 109 to 816 1 to 706       703/733
(95 %)
18 diff
(97.6 %id)
BE889555 leiomyosarcoma, uterus .c 109 to 843 1 to 740       740/946
(78 %)
13 diff
(98.7 %id)
BX480292   .c 111 to 684 1 to 575       575/579
(99 %)
9 diff
(98.5 %id)
CN255164 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 121 to 430 7 to 316       310/316
(98 %)
0 diff
(100 %id)
BG682323 skin, squamous cell carcinoma .c 127 to 955 9 to 838       830/838
(99 %)
13 diff
(98.5 %id)
TI_1948124206   .c 127 to 684 127 to 684       558/1383
(40 %)
62 diff
(95.6 %id)
CV029090 mixed .c 128 to 708 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
EL735963 mixed .c 128 to 736 1 to 609       609/613
(99 %)
1 diff
(99.9 %id)
BG913015 anaplastic oligodendroglioma with 1p/19qloss, brain .c 128 to 850 1 to 722       722/725
(99 %)
4 diff
(99.5 %id)
TI_1948124204   .c 128 to 1238 128 to 1114       752/1354
(55 %)
97 diff
(92.9 %id)
TI_1948124205   .c 128 to 1193 126 to 1065       866/1388
(62 %)
106 diff
(92.4 %id)
TI_1948124727   .c 128 to 684 130 to 686       556/1337
(41 %)
63 diff
(95.3 %id)
TI_1948125264   .c 128 to 684 124 to 680       556/1458
(38 %)
62 diff
(95.8 %id)
TI_1948125792   .c 128 to 1070 124 to 940       743/1303
(57 %)
92 diff
(93.0 %id)
BM697491 eye, fetal eyes .c 131 to 612 1 to 482       482/482
(100 %)
0 diff
(100 %id)
CN255171 embryonic stem cells, cell lines H1, H7, andH9 .c 137 to 651 1 to 515       515/515
(100 %)
0 diff
(100 %id)
BQ068706 brain, neuroblastoma, cell line .c 146 to 1059 19 to 945       927/995
(93 %)
20 diff
(98.0 %id)
BQ072289 brain, neuroblastoma, cell line .c 153 to 1066 1 to 927       927/1035
(89 %)
20 diff
(98.1 %id)
BQ956229 sciatic nerve .c 178 to 976 4 to 807       804/923
(87 %)
14 diff
(98.5 %id)
BI860150 breast, mammary adenocarcinoma, cell line .c 235 to 926 1 to 692       692/692
(100 %)
1 diff
(99.9 %id)
TI_57189979   .c 235 to 926 57 to 748       692/748
(92 %)
6 diff
(99.2 %id)
BG769678 melanotic melanoma, high MDR (cell line), skin .c 236 to 1017 1 to 783       783/785
(99 %)
15 diff
(98.1 %id)
BG767586 melanotic melanoma, high MDR (cell line), skin .c 236 to 941 1 to 707       705/707
(99 %)
2 diff
(99.8 %id)
TI_57150129   .c 244 to 1063 26 to 843       818/844
(96 %)
20 diff
(97.7 %id)
BX279871 pooled colon, kidney, stomach .c 248 to 772 1 to 525       525/525
(100 %)
0 diff
(100 %id)
BI763296 pooled colon, kidney, stomach .c 248 to 1063 1 to 814       814/815
(99 %)
14 diff
(98.3 %id)
AA375212 lung .c 319 to 667 1 to 350       350/350
(100 %)
6 diff
(98.3 %id)
CN255166 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 355 to 719 1 to 365       365/365
(100 %)
3 diff
(99.2 %id)
BQ718030 sympathetic trunk .c 369 to 1103 1 to 732       732/736
(99 %)
9 diff
(98.8 %id)
BF820135 kidney_tumor .c 394 to 626 233 to 1     Submitted on the opposite strand 233/233
(100 %)
16 diff
(93.2 %id)
BF869770 lung_tumor .c 399 to 625 227 to 1     Submitted on the opposite strand 227/272
(83 %)
1 diff
(99.7 %id)
BQ917340 sciatic nerve .c 478 to 1102 4 to 642       651/992
(65 %)
59 diff
(94.1 %id)
BE898461 adenocarcinoma cell line, ovary .c 552 to 1093 1 to 541       541/551
(98 %)
2 diff
(99.7 %id)
BQ695162 adipose .c 584 to 1107 1 to 525       525/525
(100 %)
6 diff
(98.9 %id)
BF826170 head_normal .c 592 to 1186 10 to 599       590/621
(95 %)
21 diff
(96.7 %id)
AA489753 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 595 to 768 1 to 174       174/178
(97 %)
2 diff
(98.9 %id)
BF826795 head_normal .c 596 to 1114 13 to 529       517/530
(97 %)
13 diff
(97.6 %id)
BF827668 head_normal .c 596 to 1133 27 to 569       540/643
(83 %)
28 diff
(95.7 %id)
BQ359265 head_normal .c 599 to 1134 1 to 534       534/536
(99 %)
19 diff
(96.5 %id)
BG250796 adenocarcinoma, cell line, Liver .c 660 to 1235 1 to 576       576/576
(100 %)
3 diff
(99.5 %id)
AA055365 heart .c 664 to 769 1 to 106       106/106
(100 %)
0 diff
(100 %id)
BX463144 fetal liver, Liver .c 757 to 1771 999 to 1       999/1024
(97 %)
21 diff
(98.0 %id)
AA834744 ovary .c 761 to 940 195 to 17       179/200
(89 %)
1 diff
(99.5 %id)
CD517815 White Matter .c 835 to 1471 1 to 641       641/952
(67 %)
13 diff
(98.7 %id)
BE151928 head_neck .c 877 to 1171 9 to 303       295/303
(97 %)
7 diff
(97.7 %id)
BX434774 brain, fetal brain .c 912 to 1805 890 to 4       887/890
(99 %)
20 diff
(97.8 %id)
BX354740 Neuroblastoma Cot 25-normalized .c 922 to 1793 869 to 1   fully sequenced,   869/869
(100 %)
7 diff
(99.2 %id)
BX400186   .c 953 to 1732 787 to 8   fully sequenced,   780/787
(99 %)
2 diff
(99.8 %id)
TI_154127738   .c 1069 to 1825 847 to 97   AAA   751/968
(77 %)
21 diff
(97.9 %id)
BQ014289 Chondrosarcoma, Left Pubic Bone .c 1115 to 1823 727 to 19   AAA   709/709
(100 %)
1 diff
(99.9 %id)
BQ003355 Chondrosarcoma, Left Pelvis .c 1178 to 1824 665 to 19   AAA   647/647
(100 %)
0 diff
(100 %id)
CA314780 Human Lung Epithelial cells, lung .c 1180 to 1824 665 to 19   AAA   647/651
(99 %)
9 diff
(98.7 %id)
CA417356 Chondrosarcoma Cell line .c 1203 to 1825 643 to 19   AAA   625/625
(100 %)
8 diff
(98.8 %id)
CN255169 embryonic stem cells, DMSO-treated H9 cellline .c 1224 to 1780 1 to 557       557/557
(100 %)
1 diff
(99.9 %id)
AW248957 lung, small cell carcinoma .c 1245 to 1824 590 to 11   AAA   580/580
(100 %)
1 diff
(99.9 %id)
AI675194 anaplastic oligodendroglioma, brain .c 1303 to 1830 528 to 1       528/528
(100 %)
1 diff
(99.9 %id)
AW028119 Kidney .c 1315 to 1825 518 to 7       512/518
(98 %)
0 diff
(100 %id)
AA326815 brain, cerebellum .c 1325 to 1672 1 to 349       349/349
(100 %)
2 diff
(99.5 %id)
AW952316   .c 1326 to 1714 1 to 390       390/390
(100 %)
12 diff
(97.0 %id)
BM987065 mixed .c 1331 to 1829 517 to 19   AAA   499/499
(100 %)
0 diff
(100 %id)
AI491913 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 1338 to 1824 488 to 2       487/488
(99 %)
0 diff
(100 %id)
AW452880   .c 1352 to 1833 499 to 18   AAA   482/482
(100 %)
1 diff
(99.8 %id)
AI377883 pooled .c 1396 to 1824 432 to 4       429/432
(99 %)
0 diff
(100 %id)
AI819005 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .c 1409 to 1824 416 to 1       416/416
(100 %)
3 diff
(99.3 %id)
AA635584 normal prostate, Prostate .c 1415 to 1824 411 to 1       411/413
(99 %)
4 diff
(99.1 %id)
BF446220 Prostate .c 1422 to 1824 403 to 1       403/403
(100 %)
1 diff
(99.8 %id)
AW450970   .c 1424 to 1824 418 to 18   AAA   401/401
(100 %)
1 diff
(99.8 %id)
AI866931 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 1426 to 1824 403 to 5       399/403
(99 %)
0 diff
(100 %id)
AW243832 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 1457 to 1825 370 to 2       369/380
(97 %)
0 diff
(100 %id)
AI670745 Kidney .c 1466 to 1824 360 to 2       359/360
(99 %)
0 diff
(100 %id)
AI200458 placenta .c 1470 to 1826 364 to 8       357/364
(98 %)
0 diff
(100 %id)
BQ574635 Chondrosarcoma Grade II, Left Pelvis .c 1471 to 1824 372 to 19   AAA   354/360
(98 %)
3 diff
(99.2 %id)
AI269568 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 1482 to 1824 347 to 5       343/347
(98 %)
0 diff
(100 %id)
AI634449 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 1484 to 1824 353 to 13   AAA   341/341
(100 %)
0 diff
(100 %id)
AI873666 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 1484 to 1824 341 to 1       341/341
(100 %)
2 diff
(99.5 %id)
T87766 liver and spleen .c 1489 to 1821 333 to 5       329/333
(98 %)
0 diff
(100 %id)
AW194690 Kidney .c 1511 to 1824 314 to 1       314/321
(97 %)
6 diff
(98.2 %id)
AW771866 Kidney .c 1512 to 1824 316 to 1       316/324
(97 %)
3 diff
(99.1 %id)
AL697789 human skeletal muscle .c 1543 to 1824 1 to 282   AAA   282/282
(100 %)
1 diff
(99.7 %id)
AW079488 colon, moderately differentiated adenocarcinoma .c 1554 to 1824 272 to 1       272/272
(100 %)
2 diff
(99.3 %id)
AA055697 heart .c 1562 to 1823 265 to 4       262/270
(97 %)
0 diff
(100 %id)
BU735686 eye, fetal eyes .c 1573 to 1824 270 to 19   AAA   252/252
(100 %)
1 diff
(99.7 %id)
AI306732 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 1615 to 1824 231 to 22   AAA   210/210
(100 %)
2 diff
(99.1 %id)
AW275312 brain, three pooled meningiomas .c 1620 to 1824 231 to 27   AAA   205/205
(100 %)
0 diff
(100 %id)
AA013188 eye, retina .c 1657 to 1824 172 to 2       171/172
(99 %)
0 diff
(100 %id)
BM020887 astrocytoma grade IV, cell line, brain .d 1 to 682 1 to 681   tiling clone,   681/681
(100 %)
14 diff
(98.0 %id)
TI_59387114   .d 2 to 584 56 to 639       584/584
(100 %)
4 diff
(99.4 %id)
TI_59390613   .d 2 to 682 103 to 782       680/680
(100 %)
13 diff
(98.1 %id)
BM909738 astrocytoma grade IV, cell line, brain .d 4 to 881 1 to 883   tiling clone,   883/1045
(84 %)
16 diff
(98.5 %id)
BM016876 astrocytoma grade IV, cell line, brain .d 5 to 584 1 to 581       581/581
(100 %)
4 diff
(99.4 %id)
CN255168 embryonic stem cells, cell lines H1, H7, andH9 .d 17 to 540 1 to 524       524/524
(100 %)
0 diff
(100 %id)
CN255165 embryonic stem cells, DMSO-treated H9 cellline .d 625 to 1115 1 to 492   tiling clone,   492/492
(100 %)
3 diff
(99.4 %id)
TI_149298880   .d 791 to 1532 822 to 88   AAA   735/941
(78 %)
11 diff
(98.9 %id)
BU684787 lung, Primary Lung Cystic Fibrosis EpithelialCells .d 795 to 1532 749 to 19   tiling clone, AAA   731/732
(99 %)
10 diff
(98.7 %id)
R48472 breast .e 1 to 344 1 to 351   tiling clone,   351/367
(95 %)
12 diff
(96.8 %id)
CR596796 Neuroblastoma Cot 25-normalized .e 130 to 1753 1 to 1624 exact tiling clone,   1624/1624
(100 %)
0 diff
(100 %id)
BX332993 Neuroblastoma Cot 25-normalized .e 130 to 873 1 to 742   fully sequenced,   742/742
(100 %)
4 diff
(99.5 %id)
TI_57197020   .e 501 to 1219 59 to 774       716/774
(92 %)
10 diff
(98.8 %id)
BI824693 pooled brain, lung, testis .e 503 to 1219 1 to 714       714/714
(100 %)
8 diff
(98.9 %id)
CN255163 embryonic stem cells, cell lines H1, H7, andH9 .e 520 to 1270 11 to 760       750/760
(98 %)
6 diff
(99.3 %id)
BX332992 Neuroblastoma Cot 25-normalized .e 843 to 1753 901 to 1   fully sequenced,   901/901
(100 %)
3 diff
(99.7 %id)
R48473 breast .e 1537 to 1781 246 to 1   tiling clone,   246/246
(100 %)
6 diff
(97.6 %id)
DA287101 corpus callosum .f 1 to 564 2 to 565   tiling clone, capped   564/564
(100 %)
0 diff
(100 %id)
TI_1948125263   .f 54 to 798 131 to 938       808/1461
(55 %)
6 diff
(99.6 %id)
DB307493 corpus callosum .f 1521 to 2047 527 to 1   tiling clone,   527/527
(100 %)
2 diff
(99.7 %id)
BG715386 brain, hypothalamus .g 1 to 722 1 to 722   tiling clone,   722/722
(100 %)
4 diff
(99.5 %id)
DB502055.
matches multiple genes
hypothalamus .g 6 to 475 1 to 470     also hits gene LRRC46 470/470
(100 %)
1 diff
(99.8 %id)
BX336053 Placenta Cot 25-normalized .g 19 to 1059 1 to 1024   tiling clone,   1024/1024
(100 %)
15 diff
(98.6 %id)
TI_57179976   .g 36 to 717 35 to 720       686/944
(72 %)
13 diff
(98.7 %id)
BI772403 pooled lung and spleen .g 41 to 717 1 to 681       681/905
(75 %)
6 diff
(99.4 %id)
TI_57233899   .g 45 to 823 28 to 808       781/808
(96 %)
34 diff
(95.8 %id)
BI909332 leukocyte .g 46 to 823 1 to 781       781/781
(100 %)
31 diff
(96.1 %id)
BP281482 bone marrow .g 677 to 1226 1 to 550   tiling clone,   550/550
(100 %)
7 diff
(98.8 %id)
BX361863   .g 978 to 1941 954 to 1 A2L L3*     954/1048
(91 %)
17 diff
(98.4 %id)
AW247587 lung, small cell carcinoma .g 978 to 1558 12 to 596   tiling clone,   586/596
(98 %)
6 diff
(99.0 %id)
BE899365 adenocarcinoma cell line, ovary .g 1029 to 1816 36 to 810       775/810
(95 %)
22 diff
(97.3 %id)
BX336052 Placenta Cot 25-normalized .g 1242 to 1954 718 to 6   tiling clone,   713/718
(99 %)
15 diff
(98.0 %id)
BX373915   .g 1251 to 1973 725 to 8   tiling clone,   718/797
(90 %)
16 diff
(98.0 %id)
AW245254 lung, small cell carcinoma .g 1675 to 1988 327 to 11   tiling clone, AAA   317/318
(99 %)
5 diff
(98.5 %id)
CR626068 Placenta Cot 25-normalized .h 1 to 1477 1 to 1477 exact tiling clone,   1477/1477
(100 %)
0 diff
(100 %id)
BX337654 Placenta Cot 25-normalized .h 1 to 720 1 to 719   fully sequenced,   719/719
(100 %)
1 diff
(99.9 %id)
DA570415 whole embryo, mainly head .h 13 to 792 2 to 786   capped   785/797
(98 %)
10 diff
(98.8 %id)
BX337653 Placenta Cot 25-normalized .h 690 to 1466 794 to 12   fully sequenced,   783/794
(98 %)
3 diff
(99.7 %id)
DB357183 whole embryo, mainly head .h 925 to 1493 566 to 1   tiling clone,   564/571
(98 %)
10 diff
(98.3 %id)
BI521498 pooled pancreas and spleen .i 1 to 811 6 to 820   tiling clone,   820/954
(85 %)
11 diff
(98.9 %id)
BI522692 brain .i 1 to 761 3 to 761   tiling clone,   761/761
(100 %)
5 diff
(99.4 %id)
TI_44185542   .i 1 to 761 32 to 790       761/790
(96 %)
11 diff
(98.7 %id)
CR981006 T-Lymphocytes .i 16 to 686 1 to 671   tiling clone,   671/679
(98 %)
1 diff
(99.9 %id)
BI522292 pooled pancreas and spleen .i 881 to 1562 705 to 26   tiling clone,   680/988
(68 %)
0 diff
(100 %id)
CN255162 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .j 1 to 683 1 to 684   tiling clone,   684/684
(100 %)
2 diff
(99.8 %id)
BG829628 epithelioid carcinoma cell line, Pancreas .j 646 to 1153 1 to 510   tiling clone,   510/914
(55 %)
13 diff
(98.6 %id)
BM768926 stomach .j 886 to 1456 1 to 572   tiling clone,   572/572
(100 %)
4 diff
(99.4 %id)
BM856682 stomach .j 886 to 1225 1 to 340   tiling clone,   340/340
(100 %)
1 diff
(99.8 %id)
CA396204 eye, RPE/choroid .k 1 to 534 1 to 534 exact tiling clone,   534/534
(100 %)
0 diff
(100 %id)
BI766401 pooled lung and spleen .l 1 to 769 1 to 770 exact tiling clone,   770/776
(99 %)
3 diff
(99.7 %id)
TI_57177712   .l 1 to 769 36 to 805 exact     770/811
(94 %)
9 diff
(98.9 %id)
TI_57181328   .m 1 to 836 63 to 904 exact tiling clone,   842/995
(84 %)
17 diff
(98.3 %id)
BI767388 pooled lung and spleen .m 6 to 836 1 to 837 exact tiling clone,   837/928
(90 %)
11 diff
(98.9 %id)
BP349438 brain .n 1 to 582 1 to 582 D38Y Q41H K69Y N89S N97Y ... tiling clone,   582/582
(100 %)
17 diff
(97.1 %id)
AK308989 corpus callosum Gene SCRN2, variant not shown              
AI478177 Kidney Gene SCRN2, variant not shown         Suspected internal deletion, this clone was ignored    
BE280419 choriocarcinoma, placenta Gene SCRN2, variant not shown         Suspected internal deletion, this clone was ignored    
BE796614 lung, small cell carcinoma Gene SCRN2, variant not shown         Suspected internal deletion, this clone was ignored    
BG482376 choriocarcinoma, placenta Gene SCRN2, variant not shown         Suspected internal deletion, this clone was ignored    
BG749263 eye, normal pigmented retinal epithelium Gene SCRN2, variant not shown         This clone was ignored    
BM007357 Spleen Gene SCRN2, variant not shown         Suspected internal deletion, this clone was ignored    
TI_59382513   Gene SCRN2, variant not shown         Suspected internal deletion, this clone was ignored    
TI_1948125793   Gene SCRN2, variant not shown         Suspected internal deletion, this clone was ignored    
BQ012235 placenta Gene SCRN2, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C